openPR Logo
Press release

Drug Discovery Informatics Market is Expected to Reach US$ 6 Billion by 2022

New York, May 10: Market Research Engine has published a new report titled as “Drug Discovery Informatics Market By Workflow Analysis (Development Informatics, Discovery Informatics), By Mode Analysis (In-house Informatics, Outsourced Informatics) and By Service Analysis - Global Industry Analysis and Forecast by 2022”

How Big is the Global Drug Discovery Informatics Market?

The Global Drug Discovery Informatics Market is expected to exceed more than US$ 6 Billion by 2022.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/drug-discovery-informatics-market

The drug discovery is the method in which new applicant medications are discovered. Drug discovery informatics is used in many fields such as in pharmacology, biotechnology and in medicine. Drug discovery involves the medicinal chemistry, screening hits and optimization of those hits to increase oral bioavailability, metabolic stability, efficacy, selectivity and affinity. With the beginning of innovative analytics and cloud based technology, it is feasible to store, process and analyze huge amount of data sets at lower price.

The major driving factors of Global Drug Discovery Informatics Market are as follows:

• Information technology development in the field of data mining and methodical with respect to drug expansion
• Structured and unstructured data detonation
• Increasing usage of cloud based services

The restraining factors of Global Drug Discovery Informatics Market are as follows:

• Increasing chronic illness

The Global Drug Discovery Informatics Market is segmented on the lines of its workflow, mode, service and regional. Workflow is further segmentation into development informatics and discovery informatics. Under mode segmentation it covers in house informatics and outsourced informatics. Based on service segmentation it covers clinical trial data management, sequence analysis platforms, docking, molecular modeling and others. The drug discovery informatics market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for Global Drug Discovery Informatics Market and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

3) Identifications of new market opportunities and targeted promotional plans for Global Drug Discovery Informatics Market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Global Drug Discovery Informatics Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Infosys, Certara, Charles River Laboratories, Boehringer Ingelheim GmbH, Albany Molecular Research, Selvita, DiscoverX, GVK Biosciences, ChemAxon, Novo Informatics and Jubilant Biosys. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Global Drug Discovery Informatics Market has been segmented as below:

By Workflow Analysis

• Development informatics
• Discovery informatics

By Mode Analysis

• In-house Informatics
• Outsourced Informatics

By Service Analysis

• Clinical Trial Data Management
• Sequence Analysis Platforms
• Docking
• Molecular Modeling
• Others

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all Global Drug Discovery Informatics Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast Global Drug Discovery Informatics Market data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Informatics Market is Expected to Reach US$ 6 Billion by 2022 here

News-ID: 531786 • Views: 155

More Releases from Market Research Engine Report

3D Printing Materials Market is Expected to Exceed USD 1400 Million by 2020
The 3 D Printing Materials Market is segmented based on material type, form and application. The 3 D Printing Materials Market is segmented based on material type as Plastics, Metals, Ceramics, Others. The 3 D Printing Materials Market is segmented based on form as Filament, Powder, Liquid. The 3 D Printing Materials Market is segmented based on application as Aerospace & defense, Medical & dental, Automotive, Consumer Goods,
Titanium Dioxide Market is Expected to Reach US$ 21 Billion by 2021
The global titanium dioxide market by application is segmented as paints & coatings, pulp & paper, plastics, cosmetics and other applications. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW). Browse Full Report @: https://www.marketresearchengine.com/reportdetails/titanium-dioxide-market How Big is the Global Titanium Dioxide Market? Global titanium dioxide market was accounted USD 15.5 billion in 2015. The revenue of this market is anticipated to increase
IoT Healthcare Market in North America is Expected to Grow at CAGR of 43% by 202 …
The IoT healthcare market is divided into technologies and services. The technologies segment is again analyzed by network technologies and applications technologies. The network technologies are further segmented to short range technologies and long-range technologies which are equally vital top form a connected ecosystem of healthcare. The service market is analyzed by consulting, integration and maintenance. The solution segment contributes to a majority part of the market. Browse Full Report
Nonalcoholic Steatohepatitis (NASH) Market is Expected to Cross US$ 20.0 Billion …
The Nonalcoholic Steatohepatitis market is segmented on the lines of its Therapeutics such as GFT505, Obeticholic Acid (INT-747) Simtuzumab and Liraglutide (Victoza)Vitamin EPioglitazonePlacebo. The Nonalcoholic Steatohepatitis market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Browse Full Report @: https://www.marketresearchengine.com/reportdetails/non-alcoholic-steatohepatitis-nash-market How Big is the Global Nonalcoholic Steatohepatitis (NASH) Market? Global Non-Alcoholic Steatohepatitis (NASH) market is expected to cross US$ 20.0 Billion by

All 5 Releases